| RS2150099393 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2150102490 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150102836 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150102886 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150103127 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150111242 |
SCP2
|
Health Risk |
Pathogenic |
— |
| RS2150115214 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2150115220 |
KCNN2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2150117334 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150120881 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2150120888 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2150121906 |
SCP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150125399 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2150128117 |
SLC17A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2150128669 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS2150128983 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2150129570 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150134983 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150139071 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2150140026 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2150140810 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS2150146622 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2150149041 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2150160606 |
CAMTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Inborn genetic diseases |
| RS2150160765 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2150172344 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2150172729 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150172922 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2150186856 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2150187018 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2150187539 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2150187643 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2150188102 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2150188446 |
ANKRD31
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2150189440 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150192064 |
TXNDC15
|
Health Risk |
Pathogenic |
Meckel syndrome 14, Meckel syndrome 14 |
| RS2150219160 |
COL4A4
|
Health Risk |
Pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2150219679 |
COL4A4
|
Health Risk |
Pathogenic |
COL4A4-related disorder, COL4A4-related disorder |
| RS2150220718 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150221180 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2150221409 |
COL4A4
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2150226544 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150226813 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150228286 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150231769 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2150233956 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS2150234047 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS2150234200 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS2150234491 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2150234919 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150235414 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2150236110 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 4A (Zellweger), Peroxisome biogenesis disorder 4A (Zellweger) |
| RS2150236148 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS2150238934 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with hypotonia and brain abnormalities |
| RS2150239329 |
PEX6
|
Health Risk |
Likely pathogenic |
Heimler syndrome 2, Heimler syndrome 2 |
| RS2150239487 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150239689 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150239870 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS2150239907 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150240574 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150240582 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2150245534 |
PPP2R5D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150246636 |
CLCN3
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with seizures and brain abnormalities |
| RS2150247662 |
C6
|
Health Risk |
Pathogenic |
— |
| RS2150249648 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150249865 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss, Autosomal dominant nonsyndromic hearing loss |
| RS2150250774 |
COL4A4
|
Health Risk |
Likely pathogenic |
Hematuria, benign familial |
| RS2150251009 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A4-related disorder, COL4A4-related disorder |
| RS2150254146 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with hypotonia and brain abnormalities |
| RS2150258844 |
C6
|
Health Risk |
Likely pathogenic |
— |
| RS2150267036 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with hypotonia and brain abnormalities |
| RS2150273700 |
EPB41
|
Health Risk |
Likely pathogenic |
Elliptocytosis 1, Elliptocytosis 1 |
| RS2150274994 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with hypotonia and brain abnormalities |
| RS2150275391 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2150275655 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150276003 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150276476 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150277040 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2150277252 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150277532 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2150278470 |
PPP2R5D
|
Health Risk |
Pathogenic |
Hogue-Janssens syndrome 1, Hogue-Janssens syndrome 1 |
| RS2150278773 |
PPP2R5D
|
Health Risk |
Likely pathogenic |
Encephalopathy, Encephalopathy |
| RS2150278800 |
PPP2R5D
|
Health Risk |
Likely pathogenic |
— |
| RS2150278804 |
PPP2R5D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hogue-Janssens syndrome 1, Inborn genetic diseases |
| RS2150278805 |
PPP2R5D
|
Health Risk |
Pathogenic |
Hogue-Janssens syndrome 1, Hogue-Janssens syndrome 1 |
| RS2150279502 |
CAMK2A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 53 |
| RS2150279781 |
PPP2R5D
|
Health Risk |
Pathogenic |
— |
| RS2150280830 |
CAMK2A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 53 |
| RS2150286198 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150286291 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150287805 |
CTNNA1
|
Health Risk |
Likely pathogenic |
Polyposis syndrome, hereditary mixed |
| RS2150288001 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS2150288180 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2150288556 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2150289336 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS2150289433 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2150295101 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS2150301177 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150301547 |
C6
|
Health Risk |
Pathogenic |
— |
| RS2150301790 |
ADGRV1
|
Health Risk |
Pathogenic |
— |